CBDVA

Cannabidivarinic acid

C₂₀H₂₆O₄ 330.42 g/mol Non-intoxicating (raw)

Typical abundancetrace

Receptor targets

Cyclooxygenase (COX) inhibition reported · low CB affinity

Mechanism of action

The raw acidic, propyl-chain form of CBD (CBDVA decarboxylates to CBDV). Found in propyl-rich chemotypes and reported to inhibit cyclooxygenase enzymes in vitro.

Reported effects

Anti-inflammatory (preclinical)

Common terpenes

Linalool Caryophyllene Myrcene

Research

Preclinical; of interest chiefly as the biosynthetic precursor to CBDV and as a marker of propyl chemotypes.